146.68 0.00 (0.00%)
After hours: 5:17PM EST
|Bid||146.40 x 800|
|Ask||148.00 x 1000|
|Day's Range||144.61 - 147.71|
|52 Week Range||79.26 - 176.90|
|Beta (3Y Monthly)||1.25|
|PE Ratio (TTM)||80.64|
|Earnings Date||Nov. 26, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||175.63|
Veeva Systems (VEEV) today announced it has acquired Physicians World, a leading provider of speakers bureau services. Veeva and Physicians World are joining forces to meet the industry’s need for a complete solution to plan and execute live and virtual events for healthcare professionals. Together, the companies are combining industry-leading cloud software and services to streamline events management and compliance.
Veeva Systems (VEEV) today announced that Almirall selected multichannel Veeva CRM to deliver seamless customer experience across all channels as it shifts business focus to specialty medicine. Almirall’s adoption of multichannel Veeva CRM builds upon their success with Veeva Vault PromoMats, which the company is using for commercial content and digital asset management. “We recently shifted our business strategy from primary care to specializing in dermatology and skin disease, requiring us to target a completely different set of customers,” said Carlos Sosa, director of global sales operations excellence at Almirall.
Spain’s leading pharmaceutical company drives seamless customer engagement across multiple stakeholders using face-to-face, email, and web
Veeva Systems will announce financial results for its third quarter which ended October 31, 2019 after the market close on November 26, 2019. Veeva will host a conference call and webcast that day at 1:30 p.m.
Veeva Systems (VEEV) today announced it has completed its acquisition of Crossix Solutions. Trusted by more than 200 pharmaceutical brands, Crossix provides privacy-safe U.S. patient data and a best-in-class analytics platform to help maximize media and marketing effectiveness. “We’re excited to welcome the talented Crossix team to the Veeva family,” said Veeva founder and CEO Peter Gassner.
Veeva (VEEV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CROs eliminating manual processes and modernizing systems to streamline information exchange and accelerate study start-up
While Veeva Systems Inc. (NYSE:VEEV) shareholders are probably generally happy, the stock hasn't had particularly good...
(Bloomberg) -- Software companies fell on Friday, extending recent losses after results from Atlassian Corp. topped analyst forecasts yet failed to provide enough upside to assuage concerns over the group’s valuation.Atlassian shares dropped as much as 11% to their lowest level since May. The stock was on track for its third straight decline, as was Veeva Systems Inc., off 5.4%, and ServiceNow Inc., down 3.8%, which reports its own results next week. Coupa Software Inc. sank 8.4% in its fourth straight drop, a period over which it has shed more than 20% of its valuation. Twilio Inc. was down 4.5%. Alteryx Inc. was down 7.2% and Crowdstrike Holdings Inc. dropped 7.3%, heading for the eighth decline in the past nine sessions.A basket of high-multiple software stocks tracked by Goldman Sachs fell 5.7% in its fifth straight decline, hitting its lowest since March, while the Russell Midcap Technology Growth Index was down 2.2%.“When investors have lost conviction, it usually means the best strategy is to stay conservative until the coast is at least somewhat clear,” wrote Richard Davis, an analyst at Canaccord Genuity. “We are in that time in the cycle.”Davis has a buy rating on Atlassian, writing that it “fits the description of a safe harbor company.” However, he said the stock has a “high-ish valuation” and suggested that multiples could be hard to justify. “In this macro environment,” he wrote, “if anyone expected an over-sized guide up, they haven’t been paying attention.”Recent weakness in the sector included both Workday Inc. and Zoom Video Communications Inc. tumbling in the wake of their respective investor events, which underlined growth concerns.Atlassian’s results included a raised full-year revenue forecast, and Cowen wrote that this could ease broader concerns over the sector.This “was one of the more anticipated prints in software as a result of emerging macro concerns in the space and it being one of the first to report,” analyst J. Derrick Wood wrote. The “solid numbers & outlook, along with constructive commentary on stable demand conditions, should give investors greater comfort in the potential for stability in software spending.”To contact the reporter on this story: Ryan Vlastelica in New York at email@example.comTo contact the editors responsible for this story: Catherine Larkin at firstname.lastname@example.org, Jim SilverFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
Veeva Systems (VEEV) today announced Veeva SiteVault Free, a free eRegulatory solution built specifically for clinical research sites. Now all sites can have access to a modern cloud solution to streamline trial activities and accelerate clinical research. “Veeva aims to simplify study execution so sites can focus on the critical work of clinical research and patient care,” said Peter Gassner, founder and CEO of Veeva.
Veeva Systems (VEEV) today announced that Repsco, the largest contract sales organization in France, has standardized on Veeva CRM for all their teams. A longtime partner to the life sciences industry, Repsco’s skilled medical reps help more than 30 companies bring their medicines to market. “We are committed to empowering our reps with industry leading solutions," said Philippe Tascher, general manager of Repsco.